Literature DB >> 19264772

Virus-specific cytolytic antibodies to nonstructural protein 1 of Japanese encephalitis virus effect reduction of virus output from infected cells.

Venkatramana D Krishna1, Manjuladevi Rangappa, Vijaya Satchidanandam.   

Abstract

We demonstrate the presence of nonstructural protein 1 (NS1)-specific antibodies in a significant proportion of convalescent-phase human serum samples obtained from a cohort in an area where Japanese encephalitis virus (JEV) is endemic. Sera containing antibodies to NS1 but not those with antibodies to other JEV proteins, such as envelope, brought about complement-mediated lysis of JEV-infected BHK-21 cells. Target cells infected with a recombinant poxvirus expressing JEV NS1 on the cell surface confirmed the NS1 specificity of cytolytic antibodies. Mouse anti-NS1 cytolytic sera caused a complement-dependent reduction in virus output from infected human cells, demonstrating their important role in viral control. Antibodies elicited by JEV NS1 did not cross lyse West Nile virus- or dengue virus-infected cells despite immunoprecipitating the NS1 proteins of these related flaviviruses. Additionally, JEV NS1 failed to bind complement factor H, in contrast to NS1 of West Nile virus, suggesting that the NS1 proteins of different flaviviruses have distinctly different mechanisms for interacting with the host. Our results also point to an important role for JEV NS1-specific human immune responses in protection against JE and provide a strong case for inclusion of the NS1 protein in next generation of JEV vaccines.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19264772      PMCID: PMC2682061          DOI: 10.1128/JVI.01850-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections.

Authors:  Sophie Alcon; Antoine Talarmin; Monique Debruyne; Andrew Falconar; Vincent Deubel; Marie Flamand
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

2.  Antibodies from dengue patient sera cross-react with endothelial cells and induce damage.

Authors:  Chiou-Feng Lin; Huan-Yao Lei; Ai-Li Shiau; Ching-Chuan Liu; Hsiao-Sheng Liu; Trai-Ming Yeh; Shun-Hua Chen; Yee-Shin Lin
Journal:  J Med Virol       Date:  2003-01       Impact factor: 2.327

Review 3.  Immune evasion of tumor cells using membrane-bound complement regulatory proteins.

Authors:  A Gorter; S Meri
Journal:  Immunol Today       Date:  1999-12

4.  Dengue virus nonstructural protein 1 is expressed in a glycosyl-phosphatidylinositol-linked form that is capable of signal transduction.

Authors:  M G Jacobs; P J Robinson; C Bletchly; J M Mackenzie; P R Young
Journal:  FASEB J       Date:  2000-08       Impact factor: 5.191

5.  Endothelial cell apoptosis induced by antibodies against dengue virus nonstructural protein 1 via production of nitric oxide.

Authors:  Chiou-Feng Lin; Huan-Yao Lei; Ai-Li Shiau; Hsiao-Sheng Liu; Trai-Ming Yeh; Shun-Hua Chen; Ching-Chuan Liu; Shu-Chen Chiu; Yee-Shin Lin
Journal:  J Immunol       Date:  2002-07-15       Impact factor: 5.422

6.  Cell-mediated immune responses in healthy children with a history of subclinical infection with Japanese encephalitis virus: analysis of CD4+ and CD8+ T cell target specificities by intracellular delivery of viral proteins using the human immunodeficiency virus Tat protein transduction domain.

Authors:  Priti Kumar; Venkatramana D Krishna; Paramadevanapalli Sulochana; Gejjehalli Nirmala; Maganti Haridattatreya; Vijaya Satchidanandam
Journal:  J Gen Virol       Date:  2004-02       Impact factor: 3.891

7.  Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells.

Authors:  Maria L Barilla-LaBarca; M Kathryn Liszewski; John D Lambris; Dennis Hourcade; John P Atkinson
Journal:  J Immunol       Date:  2002-06-15       Impact factor: 5.422

8.  High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever.

Authors:  Daniel H Libraty; Paul R Young; Darren Pickering; Timothy P Endy; Siripen Kalayanarooj; Sharone Green; David W Vaughn; Ananda Nisalak; Francis A Ennis; Alan L Rothman
Journal:  J Infect Dis       Date:  2002-09-16       Impact factor: 5.226

9.  Facilitation of cell adhesion by immobilized dengue viral nonstructural protein 1 (NS1): arginine-glycine-aspartic acid structural mimicry within the dengue viral NS1 antigen.

Authors:  Hsin-Hou Chang; Huey-Fen Shyu; Yo-Ming Wang; Der-Shan Sun; Rong-Hwa Shyu; Shiao-Shek Tang; Yao-Shine Huang
Journal:  J Infect Dis       Date:  2002-08-28       Impact factor: 5.226

10.  Secreted NS1 of dengue virus attaches to the surface of cells via interactions with heparan sulfate and chondroitin sulfate E.

Authors:  Panisadee Avirutnan; Lijuan Zhang; Nuntaya Punyadee; Ananya Manuyakorn; Chunya Puttikhunt; Watchara Kasinrerk; Prida Malasit; John P Atkinson; Michael S Diamond
Journal:  PLoS Pathog       Date:  2007-11       Impact factor: 6.823

View more
  23 in total

1.  A short N-terminal peptide motif on flavivirus nonstructural protein NS1 modulates cellular targeting and immune recognition.

Authors:  Soonjeon Youn; Hyelim Cho; Daved H Fremont; Michael S Diamond
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

2.  Flavivirus NS1 structures reveal surfaces for associations with membranes and the immune system.

Authors:  David L Akey; W Clay Brown; Somnath Dutta; Jamie Konwerski; Joyce Jose; Thomas J Jurkiw; James DelProposto; Craig M Ogata; Georgios Skiniotis; Richard J Kuhn; Janet L Smith
Journal:  Science       Date:  2014-02-06       Impact factor: 47.728

3.  Structural basis of Flavivirus NS1 assembly and antibody recognition.

Authors:  Melissa A Edeling; Michael S Diamond; Daved H Fremont
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-04       Impact factor: 11.205

4.  Optimized Expression of Duck Tembusu Virus E Gene Delivered by a Vectored Duck Enteritis Virus In Vitro.

Authors:  Liu Chen; Bin Yu; Jonggang Hua; Zheng Ni; Weicheng Ye; Tao Yun; Cun Zhang
Journal:  Mol Biotechnol       Date:  2019-10       Impact factor: 2.695

5.  Binding of flavivirus nonstructural protein NS1 to C4b binding protein modulates complement activation.

Authors:  Panisadee Avirutnan; Richard E Hauhart; Pawit Somnuke; Anna M Blom; Michael S Diamond; John P Atkinson
Journal:  J Immunol       Date:  2011-06-03       Impact factor: 5.422

6.  Complement-dependent cytotoxicity assay for differentiating West Nile virus from Japanese encephalitis virus infections in horses.

Authors:  Yoko Kitai; Takashi Kondo; Eiji Konishi
Journal:  Clin Vaccine Immunol       Date:  2010-03-17

7.  Complement factor H gene (CFH) polymorphisms C-257T, G257A and haplotypes are associated with protection against severe dengue phenotype, possible related with high CFH expression.

Authors:  André F Pastor; Laís Rodrigues Moura; José W D Neto; Eduardo J M Nascimento; Carlos E Calzavara-Silva; Ana Lisa V Gomes; Ana Maria da Silva; Marli T Cordeiro; Ulisses Braga-Neto; Sergio Crovella; Laura H V G Gil; Ernesto T A Marques; Bartolomeu Acioli-Santos
Journal:  Hum Immunol       Date:  2013-06-06       Impact factor: 2.850

Review 8.  West Nile virus infection and immunity.

Authors:  Mehul S Suthar; Michael S Diamond; Michael Gale
Journal:  Nat Rev Microbiol       Date:  2013-02       Impact factor: 60.633

9.  The C Terminus of the Core β-Ladder Domain in Japanese Encephalitis Virus Nonstructural Protein 1 Is Flexible for Accommodation of Heterologous Epitope Fusion.

Authors:  Li-Chen Yen; Jia-Teh Liao; Hwei-Jen Lee; Wei-Yuan Chou; Chun-Wei Chen; Yi-Ling Lin; Ching-Len Liao
Journal:  J Virol       Date:  2015-11-11       Impact factor: 5.103

10.  Structural Study of the C-Terminal Domain of Nonstructural Protein 1 from Japanese Encephalitis Virus.

Authors:  Thanalai Poonsiri; Gareth S A Wright; Michael S Diamond; Lance Turtle; Tom Solomon; Svetlana V Antonyuk
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.